BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1098217)

  • 1. Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
    Coller BS; Hirschman RJ; Gralnick HR
    Thromb Res; 1975 Jun; 6(6):469-80. PubMed ID: 1098217
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
    Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
    Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between ristocetin-induced platelet aggregation and factor VIII (activity and antigen) in v. Willebrand's disease.
    Barbui T; Battista R; Dini E
    Blut; 1974 Oct; 29(4):260-4. PubMed ID: 4547631
    [No Abstract]   [Full Text] [Related]  

  • 5. Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
    Jenkins CS; Meyer D; Dreyfus MD; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):561-78. PubMed ID: 4141901
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and von Willebrand disease.
    Ruggeri ZM; Zimmerman TS
    Semin Hematol; 1985 Jul; 22(3):203-18. PubMed ID: 3929388
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet responses to ristocetin in von Willebrand's disease.
    Sanderson JH; Burn AM; Cooke S
    Scand J Haematol; 1974; 12(4):249-55. PubMed ID: 4545782
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.
    Bouma BN; Wiegerinck Y; Sixma JJ; Van Mourik JA; Mochtar IA
    Nat New Biol; 1972 Mar; 236(65):104-6. PubMed ID: 4112547
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities.
    Hougie C; Sargeant RB; Brown JE; Baugh RF
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):58-61. PubMed ID: 4548194
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor VIII physiology and pathology in man.
    Koutts J; Howard MA; Firkin BG
    Prog Hematol; 1979; 11():115-45. PubMed ID: 392590
    [No Abstract]   [Full Text] [Related]  

  • 14. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Enhanced factor VIII activity in von Willebrand's disease.
    Mannucci PM; Pareti FI; Ruggeri ZM
    N Engl J Med; 1974 May; 290(22):1259. PubMed ID: 4545219
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemophilia and von Willebrand's disease. Some biological determinants. H. P. Smith memorial lecture.
    Brinkhous KM
    Am J Clin Pathol; 1975 May; 63(5):609-17. PubMed ID: 1093384
    [No Abstract]   [Full Text] [Related]  

  • 18. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective ristocetin and bovine factor VIII-induced platelet aggregation in normal rats.
    de Gaetano G; Donati MB; Reyers-Degli Innocenti I; Roncaglioni MC
    Experientia; 1975 Apr; 31(4):500-2. PubMed ID: 1120536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.